Brief: Titan Pharmaceuticals Says Nasdaq Provided Extension To Regain Compliance
19/03/2020 22:17
March 19 (Reuters) - Titan Pharmaceuticals Inc TTNP.O :
* TITAN PHARMACEUTICALS - RECEIVED LETTER FROM NASDAQ
PROVIDING CO
WITH 180-DAY EXTENSION TO REGAIN COMPLIANCE WITH LISTING
REQUIREMENT
Source text: (http://www.sec.gov/archives/edgar/data/910267/000110465920035935/0001104659-20-035935-index.htm
)
Further company coverage: TTNP.O
((Reuters.briefs@thomsonreuters.com;))
Recent news on Titan Pharmaceuticals
See all newsBrief: Titan Pharmaceuticals Announces $1 Million Private Placement Of Convertible Preferred Stock
Brief: Titan Pharmaceuticals- Appoints Brynner Chiam As Acting Principal Executive Officer & Acting Principal Financial Officer Of Co
U.S. STOCKS ON THE MOVE-Newmont, Monopar Therapeutics, TKO Group
Titan Pharma falls as CEO announces resignation
Brief: Titan Pharmaceuticals Enters Into Merger Agreement With Ke Sdn. Bhd.